how long have glp 1 drugs been around GLP-1 Receptor Agonist Market Size 🔮 How GLP-1s could transform
Description
Im Alane Stieglitz-Wincek
Due to the metabolic regulatory function of GLP-1RAs, they have also been considered for the treatment of other diseases such as obesity, liver disease and other metabolic dysfunction diseases (22)
Additional considerations include: Hypoglycemia : Low risk as monotherapy but increased when combined with insulin or sulfonylureas
Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes
